-
Founded in:
2013-06-21 -
Country:
China -
Address:
No. 1, Langou Road, Xuzhou Industrial Park, Jiangsu -
Tax NO.:
91320305071075704T -
Registered Funds:
100 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| 6β,7β-Epoxy-1aH,5aH-tropane-3α-ol (mono) tropate hydrobromide trihydrate |
This product is an anticholinergic drug with strong peripheral effects. The peripheral effects of this product are stronger than atropine but the duration is shorter. The central effects are mainly inhibitory. It can inhibit glandular secretion, relieve capillary spasm, improve microcirculation, dilate bronchi, relieve smooth muscle spasm; it has a sedative and hypnotic effect on the cerebral cortex and an excitatory effect on the respiratory center.
More
This product is an anticholinergic drug with strong peripheral effects. The peripheral effects of this product are stronger than atropine but the duration is shorter. The central effects are mainly inhibitory. It can inhibit glandular secretion, relieve capillary spasm, improve microcirculation, dilate bronchi, relieve smooth muscle spasm; it has a sedative and hypnotic effect on the cerebral cortex and an excitatory effect on the respiratory center. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| 6β,7β-Epoxy-1aH,5aH-tropane-3α-ol (mono) tropate hydrobromide trihydrate |
This product is an anticholinergic drug with strong peripheral effects. The peripheral effects of this product are stronger than atropine but the duration is shorter. The central effects are mainly inhibitory. It can inhibit glandular secretion, relieve capillary spasm, improve microcirculation, dilate bronchi, relieve smooth muscle spasm; it has a sedative and hypnotic effect on the cerebral cortex and an excitatory effect on the respiratory center.
More
This product is an anticholinergic drug with strong peripheral effects. The peripheral effects of this product are stronger than atropine but the duration is shorter. The central effects are mainly inhibitory. It can inhibit glandular secretion, relieve capillary spasm, improve microcirculation, dilate bronchi, relieve smooth muscle spasm; it has a sedative and hypnotic effect on the cerebral cortex and an excitatory effect on the respiratory center. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| 6β,7β-Epoxy-1aH,5aH-tropane-3α-ol (mono) tropate hydrobromide trihydrate |
This product is an anticholinergic drug with strong peripheral effects. The peripheral effects of this product are stronger than atropine but the duration is shorter. The central effects are mainly inhibitory. It can inhibit glandular secretion, relieve capillary spasm, improve microcirculation, dilate bronchi, relieve smooth muscle spasm; it has a sedative and hypnotic effect on the cerebral cortex and an excitatory effect on the respiratory center.
More
This product is an anticholinergic drug with strong peripheral effects. The peripheral effects of this product are stronger than atropine but the duration is shorter. The central effects are mainly inhibitory. It can inhibit glandular secretion, relieve capillary spasm, improve microcirculation, dilate bronchi, relieve smooth muscle spasm; it has a sedative and hypnotic effect on the cerebral cortex and an excitatory effect on the respiratory center. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cimetidine |
This product is a representative of a new class of drugs, namely histamine H2-receptor antagonists, which were first used to block the effect of histamine on parietal cell H2-receptors through a competitive inhibition mechanism. This product does not have typical anticholinergic pharmacological effects.
More
This product is a representative of a new class of drugs, namely histamine H2-receptor antagonists, which were first used to block the effect of histamine on parietal cell H2-receptors through a competitive inhibition mechanism. This product does not have typical anticholinergic pharmacological effects. |
51481-61-9 | 35 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cimetidine |
This product is a representative of a new class of drugs, namely histamine H2-receptor antagonists, which were first used to block the effect of histamine on parietal cell H2-receptors through a competitive inhibition mechanism. This product does not have typical anticholinergic pharmacological effects.
More
This product is a representative of a new class of drugs, namely histamine H2-receptor antagonists, which were first used to block the effect of histamine on parietal cell H2-receptors through a competitive inhibition mechanism. This product does not have typical anticholinergic pharmacological effects. |
51481-61-9 | 35 |